As AI systems take on increasingly consequential roles in pharmaceutical research and development, the question of how humans remain meaningfully in control has never been more important. This focused round table examines the practical and conceptual challenges of embedding human oversight into AI-driven workflows — without sacrificing the efficiency gains that make these systems so compelling.
Participants will explore frameworks for designing human-in-the-loop (HITL) systems, share lessons from real-world implementations, and debate where the balance between automation and human judgement should sit. Topics include decision validation, explainability, escalation pathways, and the organisational cultures needed to sustain responsible AI use.
This session is designed for those actively grappling with governance and trust in deployed AI systems, and those planning their next implementation who want to get the architecture right from the start.
Please note that, due to the participatory nature of this event, places are limited. Please complete the form below to register your interest in joining the discussion
Speakers include:
- Daniel Kloer Head of Digital Science & Technology R&D, Syngenta
- Daniel Kloer, Head of GTM Strategy, Sigmatic Sciences
- Marcos Camara, Director of AI Solutions, Sigmatic Sciences
- Jan Henderyckx, President, DAMA-BeLux
Register your interest